• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Moderna, Inc. - Common Stock (NQ:MRNA)

70.15 +0.12 (+0.17%)
Streaming Delayed Price Updated: 9:42 AM EDT, Jul 1, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Moderna, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
Parabilis Soared 58% in the Biggest Biotech IPO on Record. Is It Too Late to Buy the Stock? ↗
June 12, 2026
It's important to consider your comfort with risk before diving in. 
Via The Motley Fool
Topics Initial Public Offering
News headline image
3 Unpopular Stocks We Steer Clear Of
June 10, 2026
When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fea... 
Via StockStory
News headline image
Does Moderna Need to Start Making Money? ↗
June 09, 2026
Moderna Is Losing Billions. Here's Why That Might Be Exactly the Right Strategy. 
Via The Motley Fool
News headline image
Moderna and the University of Oxford Receive UK Authorization to Begin Phase 1/2 Study of Investigational mRNA Cancer Vaccine for People with Lynch Syndrome
June 08, 2026
Via ACCESS Newswire
Curious about which S&P500 stocks are generating unusual volume on Monday? Find out below. ↗
May 11, 2026
Via Chartmill
News headline image
3 ETFs For the Coming Genomics Revolution ↗
June 07, 2026
Genomics companies are an exciting frontier in health care, and ETFs can help to diversify to control risk while positioning investors to benefit. 
Via MarketBeat
Topics ETFs
News headline image
Why Is Moderna (MRNA) Stock Rocketing Higher Today
June 04, 2026
What Happened? Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 5.1% in the afternoon session after the stock's positive momentum was extended as... 
Via StockStory
Wednesday's session: top gainers and losers in the S&P500 index ↗
June 03, 2026
Via Chartmill
Platform Biotech Models Draw Investor Eyes as Drug-Delivery Markets Head Toward $410 Billion
June 03, 2026
Via Investor Brand Network
NetworkNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Featured in BioMedWire Editorial on Advanced Drug Delivery and Platform-Based Biotech Innovation
June 03, 2026
Via Investor Brand Network
Topics Artificial Intelligence Intellectual Property
News headline image
Platform Biotech Models Draw Investor Eyes as Drug-Delivery Markets Head Toward $410 Billion
June 03, 2026
From BioMedWire
Via GlobeNewswire
News headline image
Meet the Biotech Stock That's Trouncing Lilly, Merck, and Pfizer in 2026 ↗
June 03, 2026
It is finally bouncing back after several challenging years. 
Via The Motley Fool
News headline image
Moderna to Present at Upcoming Conference in June 2026
June 02, 2026
Via ACCESS Newswire
What's going on in today's session: S&P500 gap up and gap down stocks ↗
June 01, 2026
Via Chartmill
News headline image
Moderna and Merck Present 5-Year Data for Intismeran Autogene in Combination With KEYTRUDA (pembrolizumab) in Patients With High-Risk Stage III/IV Melanoma Following Complete Resection at the 2026 ASCO Annual Meeting
June 01, 2026
Via ACCESS Newswire
News headline image
Moderna and CEPI Expand Strategic Collaboration to Advance Potential Vaccine Against Bundibugyo Ebolavirus
June 01, 2026
Via ACCESS Newswire
News headline image
Anterix Stock Is Up 140%. Here's Why One Investor Just Bought $15.8 Million ↗
May 29, 2026
Anterix enables secure wireless communications for utilities and critical infrastructure through its nationwide 900 MHz spectrum portfolio. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
3 Cash-Burning Stocks with Open Questions
May 22, 2026
Companies that burn cash at a rapid pace can run into serious trouble if they fail to secure funding. Without a clear path to profitability, these businesses... 
Via StockStory
Topics Bankruptcy
News headline image
2 Healthcare Stocks Worth Investigating and 1 Facing Headwinds
May 20, 2026
Personal health and wellness is one of the many secular tailwinds for healthcare companies. But speed bumps such as inventory destockings have persisted in t... 
Via StockStory
Stay informed with the top movers within the S&P500 index on Tuesday. ↗
May 19, 2026
Via Chartmill
What's going on in today's session: S&P500 gap up and gap down stocks ↗
May 19, 2026
Via Chartmill
Explore the top gainers and losers within the S&P500 index in today's session. ↗
May 13, 2026
Via Chartmill
News headline image
3 Reasons Not to Buy Into the Hantavirus-Related Biotech Rally ↗
May 13, 2026
Investors can find much better opportunities. 
Via The Motley Fool
Exploring the top movers within the S&P500 index during today's session. ↗
May 13, 2026
Via Chartmill
Gapping S&P500 stocks in Wednesday's session ↗
May 13, 2026
Via Chartmill
News headline image
Moderna Recognized by TIME as One of the World's Most Impactful Companies
May 12, 2026
Via ACCESS Newswire
News headline image
Stock Market Today, May 11: Chipmakers Drive Midday Gains Despite Oil Concerns ↗
May 11, 2026
Today, May 11, 2026, AI chip leaders helped steady major U.S. indexes at midday as the Strait of Hormuz remains largely closed. 
Via The Motley Fool
Topics Artificial Intelligence Stocks
News headline image
Biotech Stocks Rally on Hantavirus Fears: Is the Surge Overdone? ↗
May 11, 2026
Significant news coverage and COVID-19 flashbacks have driven investors into biotech stocks over the past week. 
Via The Motley Fool
Topics Death
CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities
May 11, 2026
Via Investor Brand Network
InvestorNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Targets CNS Drug Delivery Opportunity as Brain Therapeutics Innovation Accelerates
May 11, 2026
Via Investor Brand Network
Topics Intellectual Property
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap